Identification of differential expressed lncRNAs in human thyroid cancer by a genome‐wide analyses

@article{Lu2018IdentificationOD,
  title={Identification of differential expressed lncRNAs in human thyroid cancer by a genome‐wide analyses},
  author={Wei Lu and Yongcan Xu and Jiewei Xu and Zhong Wang and Guochao Ye},
  journal={Cancer Medicine},
  year={2018},
  volume={7},
  pages={3935 - 3944}
}
Recently, a growing number of evidence has revealed that long noncoding RNAs (lncRNAs) act as key regulators in various cellular biologic processes, and dysregulation of lncRNAs involves in tumorigenesis and cancer progression. However, the expression pattern, clinical relevance, and biologic function of most lncRNAs in human thyroid cancer remain unclear. To identify more thyroid‐cancer‐associated lncRNAs, we analyzed the expression profile of lncRNAs in thyroid cancer tissues and adjacent… 
In Silico Analysis Identifies Differently Expressed lncRNAs as Novel Biomarkers for the Prognosis of Thyroid Cancer
TLDR
Bioinformatics analysis revealed 6 upregulated and 85 downregulated lncRNAs in TC samples were involved in regulating the RNA metabolic process, cell migration, organelle assembly, tRNA modification, and hormone levels.
Integrative Analysis of Methylation and Transcriptome Identified Epigenetically Regulated lncRNAs With Prognostic Relevance for Thyroid Cancer
TLDR
The crosstalk between DNA methylation and lncRNA, and the EpiLncPM, provided novel biomarkers for the prognosis of THCA.
Long non-coding RNA LIFR-AS1 regulates the proliferation, migration and invasion of human thyroid cancer cells
TLDR
The results suggest the tumor-promoting role of lncRNA-LIFR-AS1 in thyroid cancer and highlight its potential as therapeutic target and suppression of thyroid cancer tumorigenesis, in vivo.
Breast cancer overall-survival can be predicted with a 19 lncRNA tissue signature
TLDR
The BRCA prognosis risk assessment model based on 19-lncRNA can predict the prognosis of breast cancer patients and these 19 lncRNAs can be used as potential molecular markers for breast cancer prognosis prediction.
LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer
TLDR
Findings indicate that FOXD2-AS1 functions as an oncogenic regulator in the development of thyroid cancer, contributing to early recurrence of thyroid carcinoma.
Molecular mechanisms of long non-coding RNAs in anaplastic thyroid cancer: a systematic review
TLDR
There are only a small number of studies about the role of lncRNAs and their molecular mechanisms in the pathogenesis of thyroid cancer, and lnc RNAs play a crucial role in regulation of different processes involved in the development and progression of ATC.
Long Non-coding RNA RUNDC3A-AS1 Promotes Lung Metastasis of Thyroid Cancer via Targeting the miR-182-5p/ADAM9
TLDR
The results indicated that the RUNDC3A-AS1/miR-182-5p/ADAM9 axis may be a potential therapeutic target for the treatment of thyroid cancer metastasis.
...
1
2
3
4
...

References

SHOWING 1-10 OF 39 REFERENCES
Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis.
TLDR
Comprehensive expression screening identified 2 novel lncRNAs associated with risk factors of adverse prognosis in PTC patients and may be novel players in P TC carcinogenesis.
Long noncoding RNAs: emerging players in thyroid cancer pathogenesis.
TLDR
The tumor-suppressive and oncogenic roles of various lncRNAs and their possible disease associations implicated in thyroid carcinogenesis are discussed extensively.
Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer
TLDR
A role is revealed for the novel lncRNA, MANCR, in genomic stability of aggressive breast cancer, and it is identified as a potential therapeutic target.
LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge
TLDR
It is revealed that HCP5 is a tumour regulator in the development of FTC and that it may contribute to improvement of FTC diagnosis and therapy.
Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer
TLDR
LINC01234 expression was significantly upregulated in gastric cancer tissues and was associated with larger tumor size, advanced TNM stage, lymph node metastasis, and shorter survival time, and Mechanistic investigations indicated that LINC01 234 functioned as a ceRNA for miR-204-5p, thereby leading to the derepression of its endogenous target core-binding factor β (CBFB).
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1.
TLDR
Findings support a model in which the EZH2/HOXA11-AS/LSD1 complex and HOXA 11- AS/miR-1297/EZh2 cross-talk serve as critical effectors in gastric cancer tumorigenesis and progression, suggesting new therapeutic directions in gastrics cancer.
Long noncoding RNA H19 competitively binds miR‐17‐5p to regulate YES1 expression in thyroid cancer
TLDR
It is suggested that H19 functions as a competitive endogenous RNA (ceRNA) by acting as a sink for miR‐17‐5p, revealing a potential ceRNA regulatory network involving H19 and miR-17-5p with a role in the modulation of YES1 expression.
...
1
2
3
4
...